Neuronetics, Inc. Operating Cash Flow
Neuronetics, Inc. (STIM) reported Operating Cash Flow of -$10.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- Neuronetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.01M.
- Neuronetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$9.42M.
- Neuronetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $882.00K.
- Neuronetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$785.00K.
- Neuronetics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$31.00M.
- Neuronetics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$32.04M.
- Neuronetics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$30.74M.
- Neuronetics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$27.98M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$10.43M 10-Q · filed 2026-08-11 | -$9.55M derived: sum of 3 quarters · filed 2026-08-11 | -$10.33M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | -$9.42M 10-Q · filed 2026-05-05 | -$8.54M derived: sum of 2 quarters · filed 2026-08-11 | -$9.32M derived: sum of 3 quarters · filed 2026-08-11 | -$12.83M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $882.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-11 | $97.00K derived: sum of 2 quarters · filed 2026-08-11 | -$3.41M derived: sum of 3 quarters · filed 2026-08-11 | -$20.40M 10-Q · filed 2026-08-11 | -$20.37M 10-K · filed 2026-03-17 | |
| 2025-09-30 | -$785.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$4.29M derived: sum of 2 quarters · filed 2026-08-11 | -$21.28M 10-Q · filed 2025-11-04 | -$29.88M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | -$3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$20.50M 10-Q · filed 2026-08-11 | -$29.09M derived: sum of 3 quarters · filed 2026-08-11 | -$34.51M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$16.99M 10-Q · filed 2026-05-05 | -$25.59M derived: sum of 2 quarters · filed 2026-05-05 | -$31.01M derived: sum of 3 quarters · filed 2026-05-05 | -$35.98M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$14.01M derived: sum of 2 quarters · filed 2026-03-17 | -$18.98M derived: sum of 3 quarters · filed 2026-03-17 | -$31.00M 10-K · filed 2026-03-17 | ||
| 2024-09-30 | -$5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$10.39M derived: sum of 2 quarters · filed 2025-11-04 | -$22.40M 10-Q · filed 2025-11-04 | -$34.21M derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-06-30 | -$4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$16.98M 10-Q · filed 2025-08-05 | -$28.80M derived: sum of 3 quarters · filed 2026-03-17 | -$24.98M derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-03-31 | -$12.02M 10-Q · filed 2025-05-06 | -$23.83M derived: sum of 2 quarters · filed 2026-03-17 | -$20.01M derived: sum of 3 quarters · filed 2026-03-17 | -$28.84M derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2023-12-31 | -$11.81M derived: 10-K 12 month − 8-K/A 9 month · filed 2026-03-17 | -$7.99M derived: sum of 2 quarters · filed 2026-03-17 | -$16.82M derived: sum of 3 quarters · filed 2026-03-17 | -$32.04M 10-K · filed 2026-03-17 | ||
| 2023-09-30 | $3.82M derived: 8-K/A 9 month − 10-Q 6 month · filed 2025-02-06 | -$5.01M derived: sum of 2 quarters · filed 2025-02-06 | -$20.22M 8-K/A · filed 2025-02-06 | -$34.17M 10-Q · filed 2023-11-07 | -$23.32M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2023-06-30 | -$8.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$24.05M 10-Q · filed 2024-08-12 | -$27.15M derived: sum of 3 quarters · filed 2025-03-27 | -$33.65M derived: sum of 4 quarters · filed 2025-03-27 | ||
| 2023-03-31 | -$15.21M 10-Q · filed 2024-05-07 | -$18.31M derived: sum of 2 quarters · filed 2025-03-27 | -$24.82M derived: sum of 3 quarters · filed 2025-03-27 | -$33.77M derived: sum of 4 quarters · filed 2025-03-27 | ||
| 2022-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$9.61M derived: sum of 2 quarters · filed 2025-03-27 | -$18.56M derived: sum of 3 quarters · filed 2025-03-27 | -$30.74M 10-K · filed 2025-03-27 | ||
| 2022-09-30 | -$6.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$15.46M derived: sum of 2 quarters · filed 2023-11-07 | -$27.64M 10-Q · filed 2023-11-07 | -$32.16M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2022-06-30 | -$8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$21.13M 10-Q · filed 2023-08-08 | -$25.66M derived: sum of 3 quarters · filed 2024-03-08 | -$34.17M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2022-03-31 | -$12.18M 10-Q · filed 2023-05-15 | -$16.71M derived: sum of 2 quarters · filed 2024-03-08 | -$25.23M derived: sum of 3 quarters · filed 2024-03-08 | -$31.00M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2021-12-31 | -$4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$13.04M derived: sum of 2 quarters · filed 2024-03-08 | -$18.82M derived: sum of 3 quarters · filed 2024-03-08 | -$27.98M 10-K · filed 2024-03-08 | ||
| 2021-09-30 | -$8.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$14.29M derived: sum of 2 quarters · filed 2022-11-08 | -$23.46M 10-Q · filed 2022-11-08 | -$25.16M derived: sum of 4 quarters · filed 2023-03-07 | ||
| 2021-06-30 | -$5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$14.94M 10-Q · filed 2022-08-02 | -$16.64M derived: sum of 3 quarters · filed 2023-03-07 | -$20.20M derived: sum of 4 quarters · filed 2023-03-07 | ||
| 2021-03-31 | -$9.17M 10-Q · filed 2022-05-12 | -$10.87M derived: sum of 2 quarters · filed 2023-03-07 | -$14.43M derived: sum of 3 quarters · filed 2023-03-07 | -$23.91M derived: sum of 4 quarters · filed 2023-03-07 | ||
| 2020-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$5.26M derived: sum of 2 quarters · filed 2023-03-07 | -$14.74M derived: sum of 3 quarters · filed 2023-03-07 | -$28.39M 10-K · filed 2023-03-07 | ||
| 2020-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$13.04M derived: sum of 2 quarters · filed 2021-11-09 | -$26.69M 10-Q · filed 2021-11-09 | -$33.09M derived: sum of 4 quarters · filed 2022-03-08 | ||
| 2020-06-30 | -$9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$23.13M 10-Q · filed 2021-08-03 | -$29.53M derived: sum of 3 quarters · filed 2022-03-08 | -$37.20M derived: sum of 4 quarters · filed 2022-03-08 | ||
| 2020-03-31 | -$13.65M 10-Q · filed 2021-05-04 | -$20.05M derived: sum of 2 quarters · filed 2022-03-08 | -$27.71M derived: sum of 3 quarters · filed 2022-03-08 | -$34.56M derived: sum of 4 quarters · filed 2022-03-08 | ||
| 2019-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$14.06M derived: sum of 2 quarters · filed 2022-03-08 | -$20.91M derived: sum of 3 quarters · filed 2022-03-08 | -$30.48M 10-K · filed 2022-03-08 | ||
| 2019-09-30 | -$7.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$14.51M derived: sum of 2 quarters · filed 2020-11-02 | -$24.08M 10-Q · filed 2020-11-02 | -$26.36M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-06-30 | -$6.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$16.42M 10-Q · filed 2020-08-04 | -$18.69M derived: sum of 3 quarters · filed 2021-03-02 | -$23.61M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-03-31 | -$9.57M 10-Q · filed 2020-05-05 | -$11.85M derived: sum of 2 quarters · filed 2021-03-02 | -$16.76M derived: sum of 3 quarters · filed 2021-03-02 | -$21.86M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2018-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$7.19M derived: sum of 2 quarters · filed 2021-03-02 | -$12.29M derived: sum of 3 quarters · filed 2021-03-02 | -$20.59M 10-K · filed 2021-03-02 | ||
| 2018-09-30 | -$4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$10.02M derived: sum of 2 quarters · filed 2019-11-05 | -$18.32M 10-Q · filed 2019-11-05 | -$18.05M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-06-30 | -$5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$13.40M 10-Q · filed 2019-08-06 | -$13.13M derived: sum of 3 quarters · filed 2020-03-03 | -$15.06M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-03-31 | -$8.30M 10-Q · filed 2019-05-07 | -$8.03M derived: sum of 2 quarters · filed 2020-03-03 | -$9.96M derived: sum of 3 quarters · filed 2020-03-03 | |||
| 2017-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$1.66M derived: sum of 2 quarters · filed 2020-03-03 | -$11.14M 10-K · filed 2020-03-03 | -$11.10M 10-Q · filed 2018-08-14 | ||
| 2017-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$11.41M 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | -$9.48M 10-Q · filed 2018-08-14 | |||||
| 2016-12-31 | -$8.54M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |